What is bioequivalence and why is it important in toxicology for risk assessment of pharmaceuticals?

• A. Identical chemical structure
• B. Same manufacturing process
• C. Bioequivalence means similar rate and extent of systemic exposure between two formulations; important to ensure comparable safety and efficacy.
• D. Same manufacturing facility

Answer: (C)

Bioequivalence means two drug products containing the same active ingredient reach the bloodstream at essentially the same rate and to the same extent after administration. This is shown by pharmacokinetic measures such as Cmax (the peak concentration) and AUC (the overall exposure over time). If the exposure is similar, the safety and efficacy are expected to be the same, which is crucial for risk assessment in toxicology because it means interchangeable products won’t introduce unexpected toxicity or reduced effectiveness due to different absorption. It also explains why generics can be used as substitutes for brand-name drugs, even if the formulations differ in excipients or manufacturing details, as long as the systemic exposure profiles align. Identical chemical structure or producing the product in the same facility are not the determining factors for bioequivalence.